Jaguar Health (JAGX) Operating Expenses (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Operating Expenses data on file, last reported at $10.1 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 13.28% year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $55.9 million, a 28.18% increase from a year earlier, with the FY2025 full-year figure at $57.4 million, up 35.04% from the prior year.
• Operating Expenses for Q1 2026 stood at $10.1 million, down from $24.5 million in the prior quarter.
• Over the last five years, Operating Expenses for JAGX reached as high as $24.5 million in Q4 2025 and fell as low as $9.4 million in Q2 2022.
• Historically, Operating Expenses has averaged $11.8 million across 5 years, with a median of $10.8 million in 2023.
• Across the five-year window, Operating Expenses slipped 26.01% in 2022 and surged 109.81% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $9.5 million in 2022, then climbed by 3.26% to $9.9 million in 2023, then rose by 18.35% to $11.7 million in 2024, then jumped by 109.81% to $24.5 million in 2025, then sank by 58.78% to $10.1 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $10.1 million in Q1 2026, $24.5 million in Q4 2025, and $10.3 million in Q3 2025.